CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Ablating Satb1 reprograms the differentiation trajectory of exhausted CD8(+) T subsets to enhance antitumor immunity.
Ablating Satb1 reprograms the differentiation trajectory of exhausted CD8(+) T subsets to enhance antitumor immunity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的结果确定了 SATB1 是耗竭 CD8+ T 细胞亚群分化的关键调节因子,并提示将其作为靶点是一种有前景的策略,可扩增 Tex-int 群体以增强癌症免疫治疗。
在慢性感染或肿瘤中,持续的抗原暴露驱动CD8+ T细胞耗竭,这是一种异质性状态,涵盖从干细胞样祖细胞(Tpex)到过渡性效应样(Tex-int)细胞再到终末耗竭(Tex-term)亚群的分化连续体。在这些T细胞亚群中,Tex-int细胞是负责直接杀伤肿瘤细胞的主要群体。然而,调控Tpex向Tex-int转变的内在机制仍未完全明确。
在本研究中,我们探讨了特殊AT富集序列结合蛋白1(SATB1)在Tex-int细胞从其前体细胞分化过程中的作用。我们观察到在肿瘤中Tpex向Tex-int分化过程中SATB1下调。值得注意的是,在T细胞中基因敲除Satb1显著扩增了肿瘤浸润CD8+ T细胞(CD8+ TILs)的群体。
敲除 Satb1 不仅促进肿瘤微环境中 Tpex 细胞向 Tex-int 细胞分化,还通过从肿瘤特异性记忆 CD8+ T 细胞(T TSM)扩增 Tpex 池并驱动 Tpex1 向 Tpex2 转变,重塑肿瘤引流淋巴结(TdLNs)中的 T 细胞分化,从而增加肿瘤中 Tex-int 的生成。尽管 Satb1 缺陷小鼠的早期 Tex-int 细胞相对于对照组表现出短暂的功能受损,但这种差异在晚期肿瘤中不再明显,此时持续的 Tex-int 积累与显著抑制的肿瘤生长和延长的生存期相关。
In this study, we explore the role of special AT-rich sequence-binding protein 1 (SATB1) in the differentiation of Tex-int cells from their precursors. We observed downregulation of SATB1 during Tpex-to-Tex-int differentiation in tumors. Notably, the genetic ablation of Satb1 in T cells markedly expanded the population of tumor-infiltrating CD8 + T cells (CD8 + TILs).
Ablating Satb1 not only promoted the differentiation of Tex-int cells from Tpex cells within the tumor microenvironment but also remodeled T cell differentiation in tumor-draining lymph nodes (TdLNs) by expanding the Tpex pool from tumor-specific memory CD8 + T cells (T TSM ) and driving the Tpex1 to Tpex2 transition, thereby augmenting Tex-int production in tumors. Although early-stage Tex-int cells in Satb1 -deficient mice displayed transient functional impairment relative to controls, this difference was no longer evident in late-stage tumors, where sustained Tex-int accumulation correlated with significantly suppressed tumor growth and prolonged survival. DISCUSSION: Our results identify SATB1 as a pivotal regulator of exhausted CD8 + T cell subset differentiation and suggest its targeting as a promising strategy to expand the Tex-int population for enhanced cancer immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。